CD63 and melanoma: showed MBEHQ to increase melanocyte and melanoma cell immunogenicity by forming quinone haptens to the tyrosinase protein and by inducing the release of tyrosinase and melanoma antigen recognized by T cells‐1 (MART‐1)‐containing CD63+ exosomes following melanosome oxidative stress induction [8].